Kartikeya Cherabuddi

Associate professor

University of Florida

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Kartikeya Cherabuddi is an Associate Professor at the University of Florida, USA. His research focuses on infectious diseases, pharmacokinetics, and therapeutic drug monitoring, with recent publications addressing topics such as aseptic meningitis, drug monitoring in critically ill patients, and the clinical outcomes of COVID-19 patients. Dr. Cherabuddi is committed to enhancing patient care through innovative research and clinical practices.

Articles (11)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Sylvain Goutelle

Université Claude Bernard Lyon 1

FRANCE

View details

Mohammad Alshaer

University of Florida Health

UNITED STATES

View details

Charles Peloquin

Professor and Division Head

University of Florida

UNITED STATES

View details

Nathaniel Rhodes

midwestern university college of pharmacy

UNITED STATES

View details

John A. Lednicky

UNITED STATES

View details

Christopher Cogle

Professor

University of Florida College of Medicine

UNITED STATES

View details

Fekade B Sime

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kartikeya Cherabuddi

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

A Case Cluster of Aseptic Meningitis Associated With a Newly Identified Recombinant Echovirus 6/Coxsackievirus B1 Enterovirus

Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients

Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)

Digital cough monitoring – A potential predictive acoustic biomarker of clinical outcomes in hospitalized COVID-19 patients

Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity

Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center

Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics

Dissemination mechanisms of NDM genes in hospitalized patients

Vaccine Enthusiasm and Hesitancy in Cancer Patients and the Impact of a Webinar

Performance of a Semiquantitative Multiplex Bacterial and Viral PCR Panel Compared With Standard Microbiological Laboratory Results: 396 Patients Studied With the BioFire Pneumonia Panel

Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients

Collaborators (7)

Sylvain Goutelle

Mohammad Alshaer

Charles Peloquin

Nathaniel Rhodes

John A. Lednicky

Christopher Cogle

Fekade B Sime

Make your next move.